BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 5421204)

  • 1. [Results of oxypertine therapy of chronic schizophrenia].
    Marcjan K; Cwiertnia T; Wolak E
    Psychiatr Pol; 1970; 4(1):63-7. PubMed ID: 5421204
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study of oxypertine in chronic schizophrenic psychoses].
    Alapin B
    Encephale; 1971; 60(2):165-70. PubMed ID: 5564326
    [No Abstract]   [Full Text] [Related]  

  • 3. An evaluation of the efficacy of oxypertine in acute and choronic schizophrenic patients.
    Muniz AF; Terra SO; Bueno JR; Vianna Filho U
    J Bras Psiquiatr; 1968; 17(1):83-95. PubMed ID: 5760628
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary excretion of catecholamines and their metabolites in chronic schizophrenics treated with oxypertine and chlorpromazine.
    Kiriike N; Uete T; Motomura K; Enomoto M; Murata K
    Biol Psychiatry; 1984 Mar; 19(3):417-22. PubMed ID: 6144330
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: A comparison of the therapeutic effect of oxypertine and thioridazine in chronic schizophrenia (a controlled trial).
    Remr J; Nekolová J; Heinzl Z
    Act Nerv Super (Praha); 1974; 16(4):261-2. PubMed ID: 4451005
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxypertine in tardive dyskinesia.
    O'Shea B; Falvey J
    Ir Med J; 1985 Jul; 78(7):202-3. PubMed ID: 2863234
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: A comparison of Oxypertine Winthrop and chlorothepin (Clothepin Spofa) in schizophrenic psychoses.
    Uhlir F; Stevková K; Kanczucká V
    Act Nerv Super (Praha); 1975; 17(4):215. PubMed ID: 3931
    [No Abstract]   [Full Text] [Related]  

  • 8. Molindone: a controlled evaluation in chronic schizophrenic patients.
    Gallant DM; Bishop MP
    Curr Ther Res Clin Exp; 1968 Sep; 10(9):441-7. PubMed ID: 4971648
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical psychometric evaluation of the effects of fluanxol, oxipertine and chlorpromazine in chronic schizophrenia. Comparative study].
    Predescu V; Ciurezu T; Romila A; Pirée S; Vianu I; Ionescu G; Braslă N; Florescu D; David E; Roman I; Zelingher R; Ivana D; Bucurică C; Damian N
    Neurol Psihiatr Neurochir; 1969; 14(5):389-400. PubMed ID: 5380156
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative study of molindone and trifluoperazine.
    Ramsay RA; Ban TA; Lehmann HE; Saxena BM; Bennett J
    Curr Ther Res Clin Exp; 1970 Jul; 12(7):438-40. PubMed ID: 4990289
    [No Abstract]   [Full Text] [Related]  

  • 11. EEG investigations on the action of Chlordelazine, Oxypertin and Fluanxol in chronic schizophrenia.
    Predescu V; Roman I
    Electroencephalogr Clin Neurophysiol; 1969 Dec; 27(6):633-4. PubMed ID: 4188856
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical studies with oxypertine in chronically psychotic patients].
    Eckmann F; Badalik L
    Arzneimittelforschung; 1970 Feb; 20(2):268-9. PubMed ID: 5467473
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative trial of oxypertine and chlorpromazine in chronic schizophrenia.
    Neal CD; Collis MP; Imlah NW
    Curr Ther Res Clin Exp; 1969 Jun; 11(6):367-78. PubMed ID: 4979985
    [No Abstract]   [Full Text] [Related]  

  • 14. U-22,394A: a controlled evaluation in chronic schizophrenic patients.
    Gallant DM; Bishop MP; Bishop G; O'Meallie L
    Curr Ther Res Clin Exp; 1967 Nov; 9(11):579-81. PubMed ID: 4965508
    [No Abstract]   [Full Text] [Related]  

  • 15. [Our experience with oxypertine in chronic schizophrenia].
    Pascalis G; Chauvot B
    Therapie; 1968; 23(4):975-8. PubMed ID: 5744601
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: Comparison of the effect of oxypertine and thioridazine on sensorimotor activity in chronic schizophrenics (a controlled study).
    Remr J; Nekolová J; Heinzl Z
    Act Nerv Super (Praha); 1975; 17(4):213-4. PubMed ID: 3930
    [No Abstract]   [Full Text] [Related]  

  • 17. Perospirone in the treatment of schizophrenia: effect on verbal memory organization.
    Araki T; Yamasue H; Sumiyoshi T; Kuwabara H; Suga M; Iwanami A; Kato N; Kasai K
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):204-8. PubMed ID: 16300872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of parenteral molindone and haloperidol in the acutely psychotic patient.
    Binder R; Glick I; Rice M
    J Clin Psychiatry; 1981 May; 42(5):203-6. PubMed ID: 7217025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. The Sertindole Study Group.
    Daniel DG; Wozniak P; Mack RJ; McCarthy BG
    Psychopharmacol Bull; 1998; 34(1):61-9. PubMed ID: 9564200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of thiothixene in the therapy of chronic schizophrenia].
    Romaszewska K; Piotrowski A
    Psychiatr Pol; 1970; 4(1):69-71. PubMed ID: 5421205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.